Does Rallies show 13F holders for NEOG?

Yes. Rallies tracks hedge fund and 13F ownership data for NEOG, including fund names, share counts, latest tracked quarter, and position changes when available.

Is NEOG research on Rallies investment advice?

No. Rallies provides research, data, and educational context for NEOG. It does not provide personalized investment advice.

NEOG (Neogen Corp) Stock Analysis - Hedge Fund Holdings

Neogen Corp (NEOG) is a publicly traded Healthcare sector company. As of May 21, 2026, NEOG trades at $8.83 with a market cap of $1.86B and a P/E ratio of -3.07. NEOG moved +5.75% today. Year to date, NEOG is +21.63%; over the trailing twelve months it is +42.42%. Its 52-week range spans $3.87 to $17.18. Analyst consensus is buy with an average price target of $12.00. Rallies surfaces NEOG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns NEOG stock?

Hedge funds tracked by Rallies that own NEOG include Centerbook Partners, Bridgewater Associates, and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Neogen Corp.

NEOG Key Metrics

Key financial metrics for NEOG
Metric	Value
Price	$8.83
Market Cap	$1.86B
P/E Ratio	-3.07
EPS	$-2.80
Dividend Yield	0.00%
52-Week High	$17.18
52-Week Low	$3.87
Volume	3
Avg Volume	0
Revenue (TTM)	$870.54M
Net Income	$-608.84M
Gross Margin	45.20%

Top Hedge Funds Holding NEOG

Centerbook Partners holds 352.31K shares of NEOG, changed -23.47% as of Mar 31, 2026.
Bridgewater Associates holds 106.43K shares of NEOG, changed -81.80% as of Mar 31, 2026.
Mangrove Partners holds 62.01K shares of NEOG, changed +0.00% as of Jun 30, 2025.

Latest NEOG News

Neogen Q3 Revenue Falls 4.4% to $211.2M; Food Safety Up 2.6% — Apr 9, 2026
Neogen Sees Q3 EPS Drop to $0.04, Revenue Down 7.5%, Genomics Sale Boosts Shares — Apr 7, 2026
Neogen Sells Genomics Business with $90M Sales to Zoetis for $160M — Mar 2, 2026
Neogen’s Q4 Revenue Hits $224.7M, Beats Forecast by 7.2% — Feb 25, 2026
Neogen Recalls HYCOAT Vials After Microbial Contamination; Q2 Revenue Falls 2.8% — Feb 23, 2026

Recent NEOG Insider Trades

Nassif Mikheal bought 23 (~$251.62) on Feb 17, 2026.
Nassif Mikheal bought 24 (~$239.993) on Feb 2, 2026.
Nassif Mikheal bought 25 (~$246.375) on Jan 26, 2026.

NEOG Analyst Consensus

2 analysts cover NEOG: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.00.

Common questions about NEOG

Who owns NEOG stock?: Hedge funds tracked by Rallies that own NEOG include Centerbook Partners, Bridgewater Associates, and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Neogen Corp.
Does Rallies show 13F holders for NEOG?: Yes. Rallies tracks hedge fund and 13F ownership data for NEOG, including fund names, share counts, latest tracked quarter, and position changes when available.
Is NEOG research on Rallies investment advice?: No. Rallies provides research, data, and educational context for NEOG. It does not provide personalized investment advice.